Invited Commentary

Commentary on “Improving Postoperative Efficiency: An Algorithm for Expedited Void Trials After Urogynecologic Surgery”

Authors: Stephen A. Metz, MD, PhD


For many reasons, including the general aging of the US female population, women’s awareness of surgical therapies to address pelvic floor dysfunction, and the increasing acceptance of such therapies, the incidence of pelvic floor reconstructive surgery is increasing and likely will continue to increase.1

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.


1. Dieter AA, Wilkins MF, Wu JM. Epidemiological trends and future care needs for pelvic floor disorders. Curr Opin Obstet Gynecol 2015;27:380-384.
2. Hakvoort RA, Burger MP, Emanuel MH, et al. A nationwide survey to measure practice variation of catheterisation management in patients undergoing vaginal prolapse surgery. Int Urogynecol J Pelvic Floor Dysfunct 2009;20:813-818.
3. Meekins AR, Siddiqui NY, Amundsen CL, et al. Improving postoperative efficiency: an algorithm for expedited void trials after urogynecologic surgery. South Med J 2017;110:785-790.